OrthoPediatrics Corp. (KIDS) News
OrthoPediatrics Corp. (KIDS)
Today's Latest Price: $43.86 USD
Updated Jan 22 4:00pm
Add KIDS to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 186 in Medical - Devices & Equipment
See all "A" rated Strong Buy stocks
StocksNews Articles for KIDS
Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
---|---|---|---|---|---|---|---|---|---|
Loading, please wait... |
Latest KIDS News From Around the Web
Below are the latest news stories about Orthopediatrics Corp that investors may wish to consider to help them evaluate KIDS as an investment opportunity.
OrthoPediatrics Corp. Introduces Expanded Product Portfolio in CanadaWARSAW, Ind., Jan. 19, 2021 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics”) (NASDAQ: KIDS), a company exclusively focused on advancing the field of pediatric orthopedics, has obtained 14 product registrations in Canada over the past 12 months. This list includes three newly introduced Trauma & Deformity Correction products (Orthex, PNP|FEMUR and PediFoot) and features the RESPONSE Scoliosis family, which is comprised of RESPONSE 4.5/5.0 and 5.5/6.0 Systems and BandLoc, a pedicle-sparing, sublaminar banding technology. Designed with a complete focus on children, the RESPONSE system offers a simple, technologically advanced suite of instruments and implants to treat the distinct needs of pediatric patients with spinal deformities. The system features advanced instrument & im... |
ORTHOPEDIATRICS CORPORATION INVESTOR ALERT: Securities Litigation Partner James Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In OrthoPediatrics Corporation To Contact Him Directly To Discuss Their OptionsNEW YORK, Jan. 19, 2021 (GLOBE NEWSWIRE) -- Faruqi & Faruqi, LLP, a leading minority and certified woman-owned national securities law firm, is investigating potential violations of the federal securities laws against OrthoPediatrics Corporation (“OrthoPediatrics or the “Company”) (NASDAQ:KIDS). If you suffered losses exceeding $50,000 investing in OrthoPediatrics Corporation securities and would like to discuss your legal rights, click here: www.faruqilaw.com/KIDS or call Faruqi & Faruqi partner James Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). FARUQI & FARUQI, LLP685 Third Avenue, 26th Floor New York, NY [email protected] There is no cost or obligation to you. On December 2, 2020, Culper Research (“Culper”) published a that described O... |
ROSEN, RESPECTED INVESTOR COUNSEL Continues to Investigate Securities Claims Against OrthoPediatrics Corp. – KIDSRosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of OrthoPediatrics Corp. (NASDAQ: KIDS) resulting from allegations that OrthoPediatrics may have issued materially misleading business information to the investing public. |
OrthoPediatrics expands its agent network in three European countriesOrthoPediatrics ([[KIDS]] -1.1%) announced the expansion of its agent network in Germany, Austria and Switzerland by converting long-standing distributor partners to sales agencies.Under the agency model, the Company continues to benefit from the commercial relationships established by stocking distributors while it directly consigns instrument and implant sets to hospitals. This relieves the former distributors from significant... |
IMPORTANT INVESTOR NOTICE: The Schall Law Firm Announces it is Investigating Claims Against OrthoPediatrics Corp. and Encourages Investors with Losses of $100,000 to Contact the FirmLOS ANGELES, CA / ACCESSWIRE / January 15, 2021 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of OrthoPediatrics Corp. ("OrthoPediatrics" or "the Company") (NASDAQ:KIDS) for violations of the securities laws. |
OrthoPediatrics Corp. Expands its Agent Network in Three Strategic European CountriesWARSAW, Ind., Jan. 15, 2021 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced the expansion of its agent network in Germany, Austria and Switzerland. As part of its previously communicated strategy, OrthoPediatrics has broadened its reach into the largest European market of Germany, Austria and Switzerland by converting long-standing distributor partners there to sales agencies. Under the agency model, the Company continues to benefit from the commercial relationships established by stocking distributors while it directly consigns instrument and implant sets to hospitals. This relieves the former distributors from significant capital investment req... |
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Expands OrthoPediatrics (KIDS) Investigation in Light of Concurrent SEC Investigation, Analyst's Inventory Accounting Questions, Encourages Investors to Contact Its Attorneys NowSan Francisco, California--(Newsfile Corp. - January 14, 2021) - Hagens Berman urges OrthoPediatrics Corp. (NASDAQ: KIDS) investors to submit their losses now. Visit: www.hbsslaw.com/investor-fraud/KIDS Contact An Attorney Now: [email protected] 844-916-0895OrthoPediatrics Corp. (KIDS) Investigation:The investigation concerns whether OrthoPediatrics artificially inflated revenues and overstated inventory.In past quarters, OrthoPediatrics touted its "consistent 20% plus growth rate," which in turn has allowed the Company to maintain a valuation at ... |
ROSEN, A TOP RANKED LAW FIRM, Continues to Investigate Securities Claims Against OrthoPediatrics Corp. - KIDSRosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of OrthoPediatrics Corp. (NASDAQ: KIDS) resulting from allegations that OrthoPediatrics may have issued materially misleading business information to the investing public. |
Bronstein, Gewirtz & Grossman, LLC Reminds Investors of OrthoPediatrics Corp. (KIDS) InvestigationNEW YORK, NY / ACCESSWIRE / January 14, 2021 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of OrthoPediatrics Corp. ("OrthoPediatrics" or "the Company") (NASDAQ:KIDS). |
Culper Research letter to OrthoPediatrics auditor suggest increased scrutiny of inventory levelsThinly traded small-cap OrthoPediatrics ([[KIDS]] -2.6%) shares slipped modestly in apparent response to a letter to the company's auditor sent by Culper Research stating that the company's 'inventory levels deserve increased scrutiny'.It claims that the Company’s own disclosures demonstrate that a write-down of these inventories is overdue. It also cites that... |